Robert A. Hodgson
Departments of Neurobiology
Schering-Plough Research Institute
2015 Galloping Hill Road
Kenilworth
USA
Name/email consistency: high
- Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression. Hodgson, R.A., Bertorelli, R., Varty, G.B., Lachowicz, J.E., Forlani, A., Fredduzzi, S., Cohen-Williams, M.E., Higgins, G.A., Impagnatiello, F., Nicolussi, E., Parra, L.E., Foster, C., Zhai, Y., Neustadt, B.R., Stamford, A.W., Parker, E.M., Reggiani, A., Hunter, J.C. J. Pharmacol. Exp. Ther. (2009)
- Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs. Hodgson, R.A., Guthrie, D.H., Varty, G.B. Pharmacol. Biochem. Behav. (2008)
- Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Hodgson, R.A., Higgins, G.A., Guthrie, D.H., Lu, S.X., Pond, A.J., Mullins, D.E., Guzzi, M.F., Parker, E.M., Varty, G.B. Pharmacol. Biochem. Behav. (2007)